HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus. (Record no. 18525650)

MARC details
000 -LEADER
fixed length control field 02279 a2200637 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515151919.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200904s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1527-3350
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/hep.22717
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Kneteman, Norman M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20090401
245 00 - TITLE STATEMENT
Title HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Hepatology (Baltimore, Md.)
Date of publication, distribution, etc. Mar 2009
300 ## - PHYSICAL DESCRIPTION
Extent 745-52 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antiviral Agents
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Benzofurans
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease Models, Animal
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Enzyme Inhibitors
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepacivirus
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepatitis C
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepatocytes
General subdivision transplantation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interferon alpha-2
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interferon-alpha
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Liver
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mice
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mice, SCID
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Polyethylene Glycols
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recombinant Proteins
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Replicon
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ribavirin
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sulfonamides
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Viral Nonstructural Proteins
General subdivision antagonists & inhibitors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Howe, Anita Y M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gao, Tiejun
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lewis, Jamie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pevear, Dan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lund, Gary
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Douglas, Donna
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mercer, David F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tyrrell, D Lorne J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Immermann, Frederick
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chaudhary, Inder
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Speth, John
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Villano, Stephen A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name O'Connell, John
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Collett, Marc
773 0# - HOST ITEM ENTRY
Title Hepatology (Baltimore, Md.)
Related parts vol. 49
-- no. 3
-- p. 745-52
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1002/hep.22717">https://doi.org/10.1002/hep.22717</a>
Public note Available from publisher's website

No items available.